8-K filing — Scilex Holding Co (SCLXW)
Filed: 2026-08-12 AccNo: 0001193125-26-347186 Size: 263 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Filed: 2026-07-22 AccNo: 0001193125-26-312591 Size: 365 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-12 AccNo: 0001193125-26-347186 Size: 263 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits
Read original at edgarScilex Holding Company announced a binding term sheet with Kazakhstan-based iHolding Group LLP for a $100 million strategic investment at $15 per share (approximately 6.67 million shares). The investment will support Scilex's growth initiatives including product development, commercialization, acquisitions, and strategic partnerships. The deal remains subject to due diligence, definitive agreements, board and stockholder approvals, and regulatory clearances.
Read original at globenewswire-incScilex Holding Company announced that its board has set June 15, 2026 as the payment date for a dividend of Semnur Pharmaceuticals common stock to Scilex shareholders. The company plans to distribute approximately 14.0 million shares of Semnur (out of 186 million owned) on a 1:1 basis for each Scilex share held as of the June 1, 2026 record date. The dividend is subject to board revocation if there are material changes to solvency or surplus analysis.
Read original at benzinga